Thomas Julius Borody

Five Dock, Australia

Thomas Julius Borody

Average Co-Inventor Count = 1.1

ph-index = 28

Forward Citations = 2,437(Granted Patents)

Forward Citations (Not Self Cited) = 1,560(Sep 21, 2024)

DiyaCoin DiyaCoin 9.19 

Inventors with similar research interests:


Location History:

  • Five Dock N.S.W 2046, AU (1999)
  • Five Dock N.S.W. 2046, AU (2000)
  • New South Wales, 2046, AU (2001)
  • Five Dock NSW 2046, AU (1996 - 2002)
  • Five Dock, NSW 2046, AU (2002)
  • Mortlake, NSW 2137, AU (2003)
  • Five Dock, New South Wales 2046, AU (1995 - 2009)
  • New South Wales, AU (2007 - 2013)
  • Castle Hill, AU (2016 - 2018)
  • Sydney, AU (1993 - 2023)
  • Five Dock, AU (1993 - 2024)


Years Active: 1993-2025

where 'Filed Patents' based on already Granted Patents

111 patents (USPTO):
9 patents (CIPO):

Title: Thomas Julius Borody: Innovator in Infection Treatment and Microbiome Engraftment

Introduction:

Thomas Julius Borody, an esteemed inventor hailing from Five Dock, Australia, has made significant contributions to the field of medicine through his groundbreaking patents and inventions. With a total of 102 patents to his name and a focus on infection treatment and microbiome engraftment, Borody has revolutionized the way we approach healthcare. In this article, we will explore his latest patents, career highlights, collaborations, and his impact on the field.

Latest Patents:

Among Borody's recent patents, one notable invention is related to the compositions and methods for treating, ameliorating, and preventing infections. This patent describes a therapeutic combination comprising specific compositions, such as vonoprazan or a vonoprazan fumarate, along with an antimicrobial or antibiotic drug or composition. This innovative approach to infection treatment has the potential to significantly improve patient outcomes.

Additionally, Borody has made groundbreaking advancements in the field of microbiome transplantation and engraftment. His patent on gut mucosa preparation to enhance microbial engraftment outlines methods for replacing an individual's gastrointestinal microbiome through the administration of a biofilm dissolving or disrupting agent and a fecal microbiota transplantation (FMT) material. This invention has the potential to revolutionize the treatment of gastrointestinal diseases and conditions caused by an imbalanced or pathological microbiome.

Career Highlights:

Throughout his career, Borody has demonstrated an unwavering commitment to innovation and improving healthcare outcomes. Having accumulated an impressive total of 102 patents, his contributions have significantly impacted the medical industry. Borody's inventive spirit and dedication to finding novel solutions to pressing medical challenges have earned him recognition as a leading authority in the field.

Collaborations:

Borody's work has not been limited to independent endeavors. He has collaborated with several prominent colleagues, including Patrick Gosselin and Nicolas Peter Shortis. These collaborations have facilitated the exchange of ideas and expertise, leading to advancements in the fields of infection treatment and microbiome engraftment. Through these fruitful partnerships, Borody has expanded the possibilities for transforming medical treatments and improving patient outcomes.

Conclusion:

Thomas Julius Borody's exceptional contributions to the fields of infection treatment and microbiome engraftment have left an indelible mark on the medical community. With a remarkable 102 patents to his name, Borody's innovations have paved the way for more effective and personalized treatments. His inventions have the potential to reshape healthcare practices and offer new hope to patients suffering from various infections and gastrointestinal diseases. As the world continues to grapple with complex medical challenges, Borody's work serves as a testament to the power of innovation in improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…